Hexima Ltd (HXL)

Sydney
0.01
0.00(0.00%)
  • Volume:
    1,886,355
  • Bid/Ask:
    0.01/0.01
  • Day's Range:
    0.01 - 0.01
Trading near 52-week Low

HXL Overview

Prev. Close
0.01
Day's Range
0.01-0.01
Revenue
2.65M
Open
0.01
52 wk Range
0.01-0.5
EPS
-0.06
Volume
1,886,355
Market Cap
2M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,248,236
P/E Ratio
-
Beta
-
1-Year Change
-95.56%
Shares Outstanding
167,039,629
Next Earnings Date
-
What is your sentiment on Hexima?
or
Market is currently closed. Voting is open during market hours.

Hexima Ltd Analysis

Hexima Ltd Company Profile

Hexima Ltd Company Profile

Employees
0
Market
Australia

Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company’s lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. The company was incorporated in 1997 and is headquartered in Melbourne, Australia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsNeutralNeutralNeutralStrong SellStrong Sell
SummarySellSellSellStrong SellStrong Sell